Results for tag: "Porphyria Drug"

The Porphyria Drug market is a subset of the Endocrine and Metabolic Disorders Drugs market. Porphyria is a group of rare genetic disorders that affect the body's ability to produce heme, a molecule found in red blood cells. Treatment for porphyria includes drugs that can reduce the symptoms of the disorder, such as pain, nausea, and vomiting. These drugs can also help to reduce the risk of complications, such as liver damage. The Porphyria Drug market is composed of a variety of drugs, including heme-based drugs, enzyme replacement therapies, and other treatments. The Porphyria Drug market is highly competitive, with a number of companies offering products for the treatment of porphyria. Some of the major players in the market include Pfizer, Novartis, Merck, and Sanofi. Other companies in the market include AbbVie, GlaxoSmithKline, and AstraZeneca. Show Less Read more